This company has been marked as potentially delisted and may not be actively trading. NYSE:LCI Lannett (LCI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Lannett Stock (NYSE:LCI) 30 days 90 days 365 days Advanced Chart Get Lannett alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.65▼$2.5152-Week Range N/AVolume280,600 shsAverage Volume92,067 shsMarket Capitalization$7.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA. Read More Receive LCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter. Email Address LCI Stock News HeadlinesDespite Recent Weak Spots, LCI Industries Is Still Appealing At Current PricesJanuary 17, 2025 | seekingalpha.comLucky Core Industries Ltd.September 20, 2023 | wsj.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. July 15 at 2:00 AM | Porter & Company (Ad)Lannett (LCI) Stock Sinks on Lowered Guidance, Canaccord DowngradeSeptember 15, 2023 | thestreet.comLannett Company, Inc. Enters Into Restructuring Support AgreementMay 1, 2023 | finance.yahoo.comNYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSApril 20, 2023 | finance.yahoo.comLANNETT SHARES UPDATEApril 4, 2023 | finance.yahoo.comWhy Lannett (LCI) Stock Is Down TodayFebruary 26, 2023 | thestreet.comSee More Headlines LCI Stock Analysis - Frequently Asked Questions How were Lannett's earnings last quarter? Lannett Company, Inc. (NYSE:LCI) posted its earnings results on Wednesday, November, 3rd. The company reported ($1.08) earnings per share for the quarter, missing analysts' consensus estimates of ($1.00) by $0.08. The company had revenue of $101.53 million for the quarter, compared to analysts' expectations of $98.62 million. Read the conference call transcript. When did Lannett's stock split? Lannett shares reverse split on Tuesday, February 7th 2023.The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What other stocks do shareholders of Lannett own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC). Company Calendar Last Earnings11/03/2021Today7/15/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNYSE:LCI CIK57725 Webwww.lannett.com Phone(215) 333-9000Fax215-333-9004Employees810Year FoundedN/AProfitability EPS (Trailing Twelve Months)($18.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$231.62 million Net Margins-62.40% Pretax Margin-62.67% Return on EquityN/A Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio2.23 Quick Ratio1.39 Sales & Book Value Annual Sales$340.58 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($23.34) per share Price / BookN/AMiscellaneous Outstanding Shares10,770,000Free Float9,354,000Market Cap$7.38 million OptionableOptionable Beta0.95 Social Links A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NYSE:LCI) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lannett Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lannett With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
